Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxycycline Outcomes in Lupus Erythematosus (DOLE)
NCT01014260Phase 4Withdrawn
- Sponsor
- Johns Hopkins University
- Start
- Sep 2010
- Primary completion
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of doxycycline in atherosclerosis, sponsored by Johns Hopkins University. Planned start Sep 2010; status: withdrawn.
02
Drugs
doxycycline
03
Conditions
atherosclerosis
Beyond the preview
Go deeper on NCT01014260.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01014260.